Agrenvec Overview

  • Founded
  • 2002
Founded
  • Status
  • Private
  • Employees
  • 8
Employees
  • Latest Deal Type
  • 2ndary - Private
  • Investors
  • 3

Agrenvec General Information

Description

Developer of enzymes designed to specialize in plant production of mammalian recombinant proteins and antibodies. The company's enzymes produce recombinant proteins in an animal-free non-transgenic-plant system, enabling customers to increase protein expression levels and reducing purification costs.

Contact Information

Website
www.agrenvec.es
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • C/Santiago Grisolia 2, D132
  • PCM Tres Cantos
  • 28760 Madrid
  • Spain
+34 916 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Agrenvec Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private Completed Startup
2. Early Stage VC Completed Startup
1. Grant Completed Startup
To view Agrenvec’s complete valuation and funding history, request access »

Agrenvec Executive Team (9)

Name Title Board Seat Contact Info
Oriol Reig Chief Operating Officer & Managing Director
Isabel Bronchalo Director & Manager
Laura Williams Director, Laboratory
Pablo Lunello Ph.D Director, Research & Development
Rafael Ponz Co-Founder & Manager
You’re viewing 5 of 9 executive team members. Get the full list »

Agrenvec Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Agrenvec Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
AXIS Participaciones Empresariales Venture Capital Minority 000 0000 000000 0
Ministerio de Economía, Industria y Competitividad Government 000 0000 000000 0
Suanfarma Biotech Venture Capital Minority 000 0000 000000 0
To view Agrenvec’s complete investors history, request access »